CTMX position history
The shares of Cytomx Therapeutics (CTMX) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 230,000 shares, $1.1M, 0.25% of portfolio, New
- 2026 Q2: 438,407 shares, $1.6M, 0.31% of portfolio, Add +90.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|